ペニシリン酵素を産生するニセリア・ゴノレア (Neisseria gonorrhoeae) が発生する
Lancet (London, England)
|September 25, 1976
まとめ
ペニシリンGの治療は,耐性ネイセリア・ゴノレア (Neisseria gonorrhoeae) によるゴノレア性尿路炎の治療に失敗した. このバクテリアはペニシリナーゼを生成し,抗生物質の効果を低下させた.
科学分野:
- 微生物学 微生物学とは
- 感染症 感染症は感染症です.
- 抗生物質耐性菌は,抗生物質耐性菌である.
背景:
- 性感染症である淋病は,一般的にペニシリンGで治療されます.
- 尿路炎は尿路の炎症であり,しばしば細菌感染によって引き起こされます.
研究 の 目的:
- 淋病性尿路炎の症例における治療失敗の原因を調査する.
- ネイセリア・ゴノレア菌株のペニシリン感受性を決定するために,
主な方法:
- 治療失敗の臨床ケースプレゼンテーション.
- ネイセリア・ゴノレア (Neisseria gonorrhoeae) の分離と識別
- ペニシリンGのディスク拡散感受性試験
- 細菌単離体によるペニシリナーゼ生成の検出.
主要な成果:
- 患者はペニシリンGの治療に繰り返し失敗した.
- ディスク拡散試験は,ペニシリンGの10μgに対する完全な耐性を明らかにした.
- 隔離されたネイセリア・ゴノレア菌株は,ペニシリン酵素を産生することが確認された.
結論:
- ペニシリネーゼ生成は,ネイセリア・ゴノレアにおけるペニシリン耐性のメカニズムである.
- この抵抗は,ペニシリンG療法による臨床的失敗を説明する.
- 抗菌剤の感受性検査は,淋病の治療を導くために非常に重要です.
さらに関連する動画
08:04Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
Published on: February 8, 2019
07:26Metal-Limited Growth of Neisseria gonorrhoeae for Characterization of Metal-Responsive Genes and Metal Acquisition from Host Ligands
Published on: March 4, 2020
関連する概念動画
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
